Table 4.
Hazard ratio (95% CI) | P-value | |
---|---|---|
Cr Peak 48 h | ||
<1.2 mg/dL, increment +0 to 0.29 | Ref. | |
<1.2 mg/dL, increment +0.3+ | 0.79 (0.24–2.60) | 0.70 |
1.2+ mg/dL, increment +0 to 0.29 | 1.37 (0.91–2.08) | 0.13 |
1.2+ mg/dL, increment +0.3+ | 2.51 (1.65–3.81) | <0.01a |
INR (per +0.1 above 1) | 1.03 (1.00–1.05) | 0.04 |
TBILI (per +1 mg/dL above 1) | 1.02 (0.99–1.05) | 0.14 |
Na (per −1 mEq/L below 135) | 1.05 (1.01–1.09) | 0.02 |
MAP | ||
Normal (70+ mmHg) | Ref. | |
Abnormal (<70 mmHg) | 1.37 (0.89–2.11) | 0.16 |
Reason for admission | ||
6-Ref. Asc. | Ref. | |
1-Enceph. | 1.98 (1.20–3.27) | 0.01 |
7-SBP | 2.61 (1.36–5.03) | <0.01 |
8-Sepsis | 1.45 (0.82–2.58) | 0.20 |
9-GI bleed | 0.90 (0.50–1.62) | 0.73 |
Age (per +1 year) | 1.02 (1.00–1.04) | 0.02 |
Race | ||
Black or other | Ref. | |
White | 1.31 (0.93–1.85) | 0.13 |
Sex | ||
Female | Ref. | |
Male | 1.29 (0.93–1.82) | 0.13 |
Hazard ratio 1.83 (95% CI 1.24–2.70) (P < 0.01) compared to “1.2+ mg/dL, increment +0 to 0.29″. Also, Hazard ratio 3.16 (95% CI 0.96–10.48) (P = 0.06) compared to “<1.2 mg/dL, increment +0.3+”.
Interpretations:
Those with a high peak (1.2+) and high increment (+0.3+) had significantly worse survival (151% worse) than those with a low peak (<1.2) and low increment (<+0.3).
Those with a high peak and high increment also had significantly worse survival (83% worse) than those with a high peak (1.2+) and low increment (<+0.3).
These hazard ratios take into account all other variables in the table.
INR: international normalized ratio; TBILI: total bilirubin; Na: sodium; MAP: mean arterial pressure.
Single Cox regression model, adjusted for all variables in the table.
Data from 607 admissions were used. Deaths were recorded for 158 patients in this sample.